Logo

Neuland Laboratories Share Price

Neuland Laboratories (INR)14044.5-588.3   (-4%)

Exchange ScripsBSE524558NSENEULANDLABISININE794A01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Neuland Laboratories Performance

Market performance
Open price14632
High14655.3
Volumes29626
Prev Close14044.5
Low13901.1
Closing date2025-01-10
Historical performance
1 Year High18100.00
3 Year High18100.00
5 Year High18100.00
1 Year Low5387.75
3 Year Low967.00
5 Year Low245.75

Neuland Laboratories Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
17961
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
60.05
Dividend Yield
Dividend Yield
0.01 %

Neuland Laboratories Investment Returns

1 Year
154.3%
3 Years
786.9%
5 Years
2969.8%
10 Years
2624.2%

Neuland Laboratories Technicals

IndicatorsValueSignal
5-DMA14293.46Bearish
10-DMA14141.45Bearish
20-DMA14208.89Bearish
50-DMA15028.68Bearish
100-DMA13960.45Bullish
200-DMA10747.16Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1111111111
Foreign Investors22222
Domestic Investors99999
Public Investors3455629066286052771226813
Government11111

Neuland Laboratories Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income1259721161
Operating Profit4751281614471629
Interest140131135179
Depreciation597528490397
Profit Before Tax401421578221053
Consolidated Net Profit30011635638806
Adjusted EPS2341275063

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital129129129129
Total Reserves12698981282767736
Minority Interest------------
Total Non-Current Liabilities1222146717981698
Total Liabilities18326157981383513248
Capital Work in Progress459406205173
Total Assets18326157981383513248

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities261223726041894
Cash Flow from Investing Activities-1497-615-955-844
Cash Flow from Financing Activitie-693-1358377-1137
Net Cash Inflow / Outflow42239926-87
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 60.05.
  • 3Y Stock Price CAGR of the stock is 104.7.
  • The stock has a beta of 0.4.
  • In the last financial year, the company had an EBITDA of ₹4751 Million.
  • The company generated revenue of ₹15586 Million in the previous financial year.

Neuland Laboratories

14044.5-588.3   (-4%)

Investment Amount: ₹ 564370
Current Value: ₹ 1404450
Performance: 148.9%
P/L: ₹ 840080
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month